Skip to main content
×

GE.com has been updated to serve our three go-forward companies.

Please visit these standalone sites for more information

GE Aerospace | GE Vernova | GE HealthCare 

Press Release

Making Ultrasound More Accessible: GE Healthcare's New Versana Essential Combines Quality and Affordability

January 28, 2018
Press Release

В Тюмени открыт Региональный образовательный центр в области здравоохранения, созданный при поддержке GE Healthcare

January 23, 2018

ТЮМЕНЬ, Россия, 23 января 2018 г. -  В Тюмени состоялось открытие Регионального образовательного центра на площадке ГБУЗ ТО «Областной клинической больницы №1». Центр создан при поддержке GE Healthcare в рамках партнерства с правительством Тюменской области по развитию региональных образовательных проектов в сфере здравоохранения. Новая учебная площадка повысит доступность образовательных программ, направленных на рост эффективности медицинских учреждений и удовлетворенности пациентов, для региональных специалистов и управленцев сферы здравоохранения.


business unit
tags
Press Release

Clover Biopharmaceuticals selects GE's FlexFactory biomanufacturing platform for its new production facility in China

January 22, 2018

The new facility will support a robust pipeline of biopharmaceuticals, including a biosimilar to Enbrel® for the treatment of rheumatoid arthritis


business unit
Press Release

CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare's New Start-to-Finish Solution

January 18, 2018

·         GE supports CBMG in its aim to speed up manufacturing timelines for its CAR T-cell therapy clinical trials and future commercialization

·         First GE Healthcare FlexFactory™ for cell therapy installation in the world will  provide CBMG with scalable, fully-equipped cell therapy manufacturing capabilities, training and services 


business unit
Press Release

First imaging agent of its kind now approved in Canada to help physicians in the diagnosis of patients with suspected Parkinsonian Syndromes

January 11, 2018

CHALFONT ST. GILES, UK, 11 January 2018 - GE Healthcare announced today the approval in Canada of DaTscan™ (Ioflupane I 123 Injection), the first Health Canada approved radiopharmaceutical adjunct imaging agent to help physicians evaluate patients with a suspected parkinsonian syndrome (PS) such as Parkinson’s disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). DaTscan is unable to discriminate between PD, MSA and PSP.


business unit
Press Release

GE, Roche Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment

January 08, 2018
  • Companies aim to develop jointly-branded clinical decision support software for faster, more accurate, more confident decision-making, enabling earlier diagnosis and individualized treatment
  • Partnership will apply advanced analytics to in-vivo data from GE’s medical imaging and monitoring equipment with in-vitro data from Roche’s biomarker, tissue pathology, genomics and sequencing portfolio

Chicago, USA Jan 8, 2018 - GE Healthcare has entered into a strategic, long-term partnership with Roche (SIX: RO, ROG; OTCQX: RHHBY) to jointl


business unit
Press Release

GE открыла новое производство медицинского диагностического оборудования на площадке АО «МТЛ» в Подмосковье

December 21, 2017

МОСКВА, Россия, 21 декабря 2017 г. -  Сегодня GE Healthcare открыла в Подмосковье новое производство высокотехнологичного медицинского диагностического оборудования для обеспечения потребностей населения страны доступом к качественному медицинскому обслуживанию. Производственная площадка, открытая в партнерстве с АО «МТЛ», будет выпускать новейшие модели компьютерных томографов и ультразвуковых систем GE, не имеющие российских аналогов в соответствующих сегментах.


business unit
tags
Press Release

Lifespan and GE Healthcare Put New Plan in Place to Reduce Care Delivery Costs by $182 Million over Six Years

December 18, 2017

Goal to transform health care delivery and provide more affordable, world-class care


business unit
Press Release

A message to our Customers

November 28, 2017

GE Healthcare's priority is to provide safe products that help improve patient health. Recent publications indicate low levels of gadolinium are retained in the brain following repeated exposure to gadolinium-based contrast agents (GBCAs). We take very seriously any information concerning possible adverse events associated with our products.


business unit
Press Release

GE Healthcare acquires bioprocessing start-up Puridify

November 24, 2017

UK start-up is developing nanofiber technology to improve how medicine is manufactured

Chalfont St Giles, UK - 28 November 2017 - GE Healthcare has completed the acquisition of Puridify, a bioprocessing start-up that is developing a nanofiber-based platform purification technology for biopharmaceutical production. Puridify’s technology, FibroSelect, is complementary to the bead resins and chromatography membranes used today in downstream bioprocessing, promising faster mass transfer, scalability and ease of use. 


business unit
Subscribe to GE Healthcare